Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
Technology appraisal guidance [TA119]
Published:
28 February 2007
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
Title
Year published
Impact Level
No results could be found